170 related articles for article (PubMed ID: 9718987)
1. Chronic non-peptide neurokinin receptor antagonist treatment alters striatal tachykinin peptide and receptor gene expression in the rat.
McCarson KE; Krause JE; McLean S
Neurosci Lett; 1998 Jul; 251(2):113-6. PubMed ID: 9718987
[TBL] [Abstract][Full Text] [Related]
2. The new neurokinin 1-sensitive receptor mediates the facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after suppression of dopaminergic transmission in the matrix of the rat striatum.
Kemel ML; Pérez S; Beaujouan JC; Jabourian M; Soubrié P; Glowinski J
J Neurochem; 2003 Oct; 87(2):487-96. PubMed ID: 14511126
[TBL] [Abstract][Full Text] [Related]
3. The neurokinin-1 receptor antagonist LY306,740 blocks nociception-induced increases in dorsal horn neurokinin-1 receptor gene expression.
McCarson KE; Krause JE
Mol Pharmacol; 1996 Nov; 50(5):1189-99. PubMed ID: 8913350
[TBL] [Abstract][Full Text] [Related]
4. Effects of selective tachykinin-receptor antagonists on tachykinin-induced airway mucus secretion in the rat.
Wagner U; Fehmann H; Bredenbröker D; Klüber D; Lange A; Wichert P
Neuropeptides; 1999 Feb; 33(1):55-61. PubMed ID: 10657472
[TBL] [Abstract][Full Text] [Related]
5. Expression of substance P and its neurokinin-1 receptor on thymocytes: functional relevance in the regulation of thymocyte apoptosis and proliferation.
Santoni G; Amantini C; Lucciarini R; Pompei P; Perfumi M; Nabissi M; Morrone S; Piccoli M
Neuroimmunomodulation; 2002-2003; 10(4):232-46. PubMed ID: 12584411
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1beta upregulates functional expression of neurokinin-1 receptor (NK-1R) via NF-kappaB in astrocytes.
Guo CJ; Douglas SD; Gao Z; Wolf BA; Grinspan J; Lai JP; Riedel E; Ho WZ
Glia; 2004 Nov; 48(3):259-66. PubMed ID: 15390113
[TBL] [Abstract][Full Text] [Related]
7. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
Cheng FH; Chan SW; Rudd JA
Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
[TBL] [Abstract][Full Text] [Related]
8. Aprepitant limits in vivo neuroinflammatory responses in a rhesus model of Lyme neuroborreliosis.
Martinez AN; Burmeister AR; Ramesh G; Doyle-Meyers L; Marriott I; Philipp MT
J Neuroinflammation; 2017 Feb; 14(1):37. PubMed ID: 28202084
[TBL] [Abstract][Full Text] [Related]
9. Role of tachykinin and neurokinin receptors in the regulation of ovine omasal contractions.
Onaga T; Oh-ishi T; Shimoda T; Nishimoto S; Hayashi H
Regul Pept; 2012 Jan; 173(1-3):64-73. PubMed ID: 21971117
[TBL] [Abstract][Full Text] [Related]
10. Effects of haloperidol and clozapine on preprotachykinin-A messenger RNA, tachykinin tissue levels, release and neurokinin-1 receptors in the striato-nigral system.
Humpel C; Knaus GA; Auer B; Knaus HG; Haring C; Theodorsson E; Saria A
Synapse; 1990; 6(1):1-9. PubMed ID: 1697986
[TBL] [Abstract][Full Text] [Related]
11. The substance P/neurokinin-1 receptor system in lung cancer: focus on the antitumor action of neurokinin-1 receptor antagonists.
Muñoz M; González-Ortega A; Rosso M; Robles-Frias MJ; Carranza A; Salinas-Martín MV; Coveñas R
Peptides; 2012 Dec; 38(2):318-25. PubMed ID: 23026680
[TBL] [Abstract][Full Text] [Related]
12. Intranigral injection of selective neurokinin-1 and neurokinin-3 but not neurokinin-2 receptor agonists biphasically modulate striatal dopamine metabolism but not striatal preprotachykinin-A mRNA in the rat.
Humpel C; Saria A
Neurosci Lett; 1993 Jul; 157(2):223-6. PubMed ID: 7694197
[TBL] [Abstract][Full Text] [Related]
13. A tachykinin NK1 receptor antagonist, CP-122,721-1, attenuates kainic acid-induced seizure activity.
Zachrisson O; Lindefors N; Brené S
Brain Res Mol Brain Res; 1998 Oct; 60(2):291-5. PubMed ID: 9757066
[TBL] [Abstract][Full Text] [Related]
14. Substance P and cholecystokinin regulate neurochemical responses to cocaine and methamphetamine in the striatum.
Loonam TM; Noailles PA; Yu J; Zhu JP; Angulo JA
Life Sci; 2003 Jun; 73(6):727-39. PubMed ID: 12801594
[TBL] [Abstract][Full Text] [Related]
15. Tachykinin regulation of cholinergic transmission in the limbic/prefrontal territory of the rat dorsal striatum: implication of new neurokinine 1-sensitive receptor binding site and interaction with enkephalin/mu opioid receptor transmission.
Pérez S; Tierney A; Deniau JM; Kemel ML
J Neurochem; 2007 Dec; 103(6):2153-63. PubMed ID: 17949415
[TBL] [Abstract][Full Text] [Related]
16. Respiratory actions of tachykinins in the nucleus of the solitary tract: characterization of receptors using selective agonists and antagonists.
Mazzone SB; Geraghty DP
Br J Pharmacol; 2000 Mar; 129(6):1121-31. PubMed ID: 10725260
[TBL] [Abstract][Full Text] [Related]
17. The role of the amino-terminal domain of tachykinins in neurokinin-1 receptor signaling and desensitization.
Vigna SR
Neuropeptides; 2003 Feb; 37(1):30-5. PubMed ID: 12637033
[TBL] [Abstract][Full Text] [Related]
18. Lack of induction of substance P gene expression by hypoxia and absence of neurokinin 1-receptor mRNAs in the rat carotid body.
Gauda EB; Bamford OS; Northington FJ
J Auton Nerv Syst; 1998 Dec; 74(2-3):100-8. PubMed ID: 9915624
[TBL] [Abstract][Full Text] [Related]
19. Are biological actions of neurokinin A in the adult brain mediated by a cross-talk between the NK1 and NK2 receptors?
Tauer U; Zhao Y; Hunt SP; Culman J
Neuropharmacology; 2012 Nov; 63(6):958-65. PubMed ID: 22771977
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous quantitation of substance P-encoding preprotachykinin alternatively spliced mRNAs and substance P receptor NK-1 mRNA by an RNase protection assay.
Gautreau A; Kerdelhué B
Brain Res Brain Res Protoc; 1998 Jan; 2(2):133-40. PubMed ID: 9473630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
